Top 4 search results for "fotivda" in Resources. To see all results and access other features, sign up for free.

... Ongoing clinical trials are studying more of these combinations to treat clear cell RCC, papillary RCC, and other kidney cancer types.Tivozanib for Relapsed Advanced Renal Cell CarcinomaIn March 2021, the FDA approved a targeted therapy drug called tivozanib (Fotivda) to treat relapsed or refractory (unresponsive to treatment) advanced RCC in adults ...

... adjuvant therapy to lower the risk of recurrence after surgery.Several different targeted therapy drugs can be used to treat kidney cancer, including: Axitinib (Inlyta) Belzutifan (Welireg) Bevacizumab (Avastin) Cabozantinib (Cabometyx) Everolimus (Afinitor) Lenvatinib (Lenvima) Pazopanib (Votrient) Sunitinib (Sutent) Temsirolimus (Torisel) Tivozanib (Fotivda ...

... Most TKIs are FDA-approved to treat RCC.Examples of TKIs include: Axitinib (Inlyta) Cabozantinib (Cabometyx) Lenvatinib (Lenvima) Pazopanib (Votrient) Sorafenib (Nexavar) Sunitinib (Sutent) Tivozanib (Fotivda) Your doctor will choose a TKI depending on other treatments you’ve tried before. ...

... Without a blood supply, tumors have a harder time getting the oxygen and nutrients they need to grow.Targeted therapies used for kidney cancer include: Axitinib Belzutifan (Welireg) Cabozantinib (Cabometyx) Lenvatinib (Lenvima) Pazopanib (Votrient) Sunitinib malate (Sutent) Tivozanib (Fotivda) These medicines are often part of combination treatments ...